Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04656899 · ClinicalTrials.gov registry record · NA
Mobile Medication Adherence Platform for Buprenorphine-Naloxone During Treatment of Opioid Use Disorder: Phase I Study
A NA study, sponsored by Washington State University.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT04656899 is a NA study that has completed, run by Washington State University. The registered enrollment target is 41 participants.
The verdict
NCT04656899, a NA study, has completed, sponsored by Washington State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The investigators will conduct a phase I study involving 41 participants selected randomly among patients prescribed buprenorphine-naloxone for opioid misuse as a feasibility trial of the study of the Pillsy device. The study will track the effectiveness of the Pillsy technology and associated smartphone application by measuring adherence to buprenorphine-naloxone therapy and patient satisfaction with the application and the Pillsy device.
Interventions
- BEHAVIORAL Reminders messages to improve adherence.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2020-12-06 |
| Est. Completion | 2021-10-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04656899
The ClinicalTrials.gov registry entry for NCT04656899 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington State University, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Reminders messages to improve adherence. is the first listed.
NCT04656899 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04656899 about?
NCT04656899 is a clinical study titled "Mobile Medication Adherence Platform for Buprenorphine-Naloxone During Treatment of Opioid Use Disorder: Phase I Study". The investigators will conduct a phase I study involving 41 participants selected randomly among patients prescribed buprenorphine-naloxone for opioid misuse as a feasibility trial of the study of the Pillsy device. The study will track the effectiveness of the Pillsy technology and associated smart...
What is the current status of trial NCT04656899?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2020-12-06. Estimated completion is 2021-10-11.
What interventions are being tested in trial NCT04656899?
The interventions under investigation include: Reminders messages to improve adherence. (BEHAVIORAL).
Who is sponsoring clinical trial NCT04656899?
This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.